BiondVax’s Financial Reports and Results
Please select from the links below to the financial reports with BiondVax’s quarterly and year-end financial results.
Results Period |
Press Release |
Report |
XBRL |
Q1 2023 |
|||
FY 2022 |
HTML | ||
Q3 2022 |
|||
Q2 2022 |
|||
Q1 2022 |
|||
FY & Q4 2021 |
ZIP | ||
Q3 2021 |
|||
Q2 2021 |
|||
Q1 2021 |
|||
FY & Q4 2020 |
ZIP | ||
Q3 2020 |
|||
Q2 2020 |
|||
Q1 2020 |
|||
FY & Q4 2019 |
|||
Q3 2019 |
|||
Q2 2019 |
|||
Q1 2019 |
|||
FY & Q4 2018 |
|||
Q3 2018 |
|||
Q2 2018 |
|||
Q1 2018 |
|||
FY & Q4 2017 |
|||
Q3 2017 |
|||
Q2 2017 |
|||
Q1 2017 |
|||
FY & Q4 2016 |
|||
Q3 2016 |
|||
Q2 2016 |
|||
Q1 2016 |
|||
FY & Q4 2015 |
BiondVax routinely files periodic reports with the SEC. Note that BiondVax files with the SEC as a foreign filer. Click here to view SEC Filings.
Note: The above includes hyperlinks to a third-party SEC Filings web site. BiondVax does not maintain or provide information directly to this site. BiondVax makes no representations or warranties with respect to the information contained in this site.